Body surface potential mapping: contemporary applications and future perspectives

J Bergquist, L Rupp, B Zenger, J Brundage, A Busatto… - Hearts, 2021 - mdpi.com
Body surface potential mapping (BSPM) is a noninvasive modality to assess cardiac
bioelectric activity with a rich history of practical applications for both research and clinical …

Protective effects of 6-gingerol on cardiotoxicity induced by arsenic trioxide through AMPK/SIRT1/PGC-1α signaling pathway

X Han, Y Yang, M Zhang, X Chu, B Zheng… - Frontiers in …, 2022 - frontiersin.org
Background and Objective: Arsenic trioxide (As2O3) induced cardiotoxicity to limit the
clinical applications of the effective anticancer agent. 6-Gingerol (6G) is the main active …

Tipping the scales of understanding: An engineering approach to design and implement whole-body cardiac electrophysiology experimental models

B Zenger, JA Bergquist, A Busatto, WW Good… - Frontiers in …, 2023 - frontiersin.org
The study of cardiac electrophysiology is built on experimental models that span all scales,
from ion channels to whole-body preparations. Novel discoveries made at each scale have …

The Role of Beta-1 Receptors in the Response to Myocardial Ischemia

LC Rupp, B Zenger, JA Bergquist… - 2022 Computing in …, 2022 - ieeexplore.ieee.org
Acute myocardial ischemia is commonly diagnosed by ST-segment deviations. These
deviations, however, can show a paradoxical recovery even in the face of ongoing ischemic …

[PDF][PDF] Body Surface Potential Mapping: Contemporary Applications and Future Perspectives. Hearts 2021, 2, 514–542

J Bergquist, L Rupp, B Zenger, J Brundage… - The Application of …, 2021 - core.ac.uk
Body surface potential mapping (BSPM) is a noninvasive modality to assess cardiac
bioelectric activity with a rich history of practical applications for both research and clinical …

[PDF][PDF] Machine Learning Estimation of Myocardial Ischemia Severity Using Body Surface ECG

R Jin, JA Bergquist, D Dade, B Zenger, X Ye, R Ranjan… - cinc.org
Acute myocardial ischemia (AMI) is one of the leading causes of cardiovascular deaths
around the globe. Yet, clinical early detection and patient risk stratification of AMI remain an …